PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2040654-8	1991	DFMO decreased the cellular levels of putrescine and spermidine and suppressed IL-1 beta release and IL-1 beta mRNA expression by 65%.	Eflornithine	0-4	interleukin 1 beta	Homo sapiens	101-110	
9397163-6	1998	alpha-Difluoromethylornithine (DFMO) pretreatment, by lowering putrescine and spermidine in HGF- or IL-1 beta-treated cells, prevented the induction of cSAT.	Eflornithine	0-29	interleukin 1 beta	Homo sapiens	100-109	
9397163-6	1998	alpha-Difluoromethylornithine (DFMO) pretreatment, by lowering putrescine and spermidine in HGF- or IL-1 beta-treated cells, prevented the induction of cSAT.	Eflornithine	31-35	interleukin 1 beta	Homo sapiens	100-109	
9397163-9	1998	DFMO prevented almost completely the enhancement of c-jun mRNA expression by IL-1 beta, and this effect was reversed by exogenous putrescine or spermidine.	Eflornithine	0-4	interleukin 1 beta	Homo sapiens	77-86	
2040654-7	1991	To find whether these peaks were related to IL-1 beta production, DL-alpha-difluoromethylornithine (DFMO), a specific irreversible inhibitor of ODC, was added together with TPA and 1,25(OH)2D3.	Eflornithine	66-98	interleukin 1 beta	Homo sapiens	44-53	
28707668-8	2017	It has been demonstrated that, in cells transfected with HCV genes, DFMO reduces the production of three out of four tested cytokines, namely, TNF-alpha and TGF-beta in cells that express HCV core, E1E2, NS3, NS5A, and NS5B proteins, and IL-1beta in the cells that express HCV core, E1E2, and NS3 proteins.	Eflornithine	68-72	interleukin 1 beta	Homo sapiens	238-246	
2040654-8	1991	DFMO decreased the cellular levels of putrescine and spermidine and suppressed IL-1 beta release and IL-1 beta mRNA expression by 65%.	Eflornithine	0-4	interleukin 1 beta	Homo sapiens	79-88